Acknowledgement
This study was financially supported by Dongnam Health University.
References
- Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015;4:101-108. https://doi.org/10.3978/j.issn.2304-3881.2015.01.03
- Blendea MC, Thompson MJ, Malkani S. Diabetes and chronic liver disease: etiology and pitfalls in monitoring. Clin Diabetes. 2010;28:139-144. https://doi.org/10.2337/diaclin.28.4.139
- Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study. BMJ Open Diabetes Res Care. 2020;8:e001629. https://doi.org/10.1136/bmjdrc-2020-001629
- Leite NC, Villela-Nogueira CA, Cardoso CR, Salles GF. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. World J Gastroenterol. 2014;20: 8377-8392. https://doi.org/10.3748/wjg.v20.i26.8377
- Lee SJ, Lee BW. Diabetes mellitus and non-alcoholic fatty liver disease: diagnosis and treatment. J Korean Diabetes. 2021;22:38-45. https://doi.org/10.4093/jkd.2021.22.1.38
- Niu H, Zhou Y. Nonlinear relationship between AST-to-ALT ratio and the incidence of type 2 diabetes mellitus: a follow-up study. Int J Gen Med. 2021;14:8373-8382. https://doi.org/10.2147/IJGM.S341790
- Botros M, Sikaris KA. The de ritis ratio: the test of time. Clin Biochem Rev. 2013;34:117-130.
- Lala V, Zubair M, Minter DA. Liver function tests [Internet]. Treasure Island: StatPearls Publishing [cited 2022 November 15]. Available from: https://europepmc.org/article/med/29494096
- Kumar R. Hepatogenous diabetes: an underestimated problem of liver cirrhosis. Indian J Endocrinol Metab. 2018;22:552-559. https://doi.org/10.4103/ijem.IJEM_79_18
- Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet. 1967;2:1051-1056. https://doi.org/10.1016/s0140-6736(67)90334-0
- Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? Liver Int. 2017;37:950-962. https://doi.org/10.1111/liv.13337
- McClatchey KD. Clinical laboratory medicine. 2nd ed. Philadelphia: Williams & Wilkins; 2002. p288-290.
- Chen L, Zhang K, Li X, Wu Y, Liu Q, Xu L, et al. Association between aspartate aminotransferase to alanine aminotransferase ratio and incidence of type 2 diabetes mellitus in the Japanese population: a secondary analysis of a retrospective cohort study. Diabetes Metab Syndr Obes. 2021;14:4483-4495. https://doi.org/10.2147/DMSO.S337416
- Chen W, Wang W, Zhou L, Zhou J, He L, Li J, et al. Elevated AST/ALT ratio is associated with all-cause mortality and cancer incident. J Clin Lab Anal. 2022;36:e24356. https://doi.org/10.1002/jcla.24356
- Christman AL, Lazo M, Clark JM, Selvin E. Low glycated hemoglobin and liver disease in the U.S. population. Diabetes Care. 2011;34:2548-2550. https://doi.org/10.2337/dc11-0944
- Al-Jameil N, Khan FA, Arjumand S, Khan MF, Tabassum H. Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients. Int J Clin Exp Pathol. 2014;7:4345-4349.
- Stefan N, Haring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7:313-324. https://doi.org/10.1016/S2213-8587(18)30154-2
- Yadav R, Bhartiya JP, Verma SK, Nandkeoliar MK. The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions. J Clin Diagn Res. 2013;7:1291-1294. https://doi.org/10.7860/JCDR/2013/6016.3120